Normal view MARC view ISBD view

Effects of alpha-tocopherol and ascorbyl palmitate on the isomerization and decomposition of methyl linoleate hydroperoxides. [electronic resource]

By:

Mäkinen, E M

Contributor(s):

Hopia, A I

Producer: 20010215Description: 1215-23 p. digitalISSN:

0024-4201

Subject(s):

Online resources:

Available from publisher's website

In: Lipids vol. 35

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

401 Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors.
by Sanchez, P V
402 Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor.
by Kotani, Hitoshi
403 Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
by Kuntz, Mélanie
404 An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease.
by Habchi, Johnny
405 Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
by Knol, Anne Chantal
406 Treatment of cutaneous T-cell lymphoma/mycosis fungoides.
by Parker, Sareeta R S
407 Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.
by Ying, Shao Xu
408 Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
by Boerma, Leeann J
409 [LGD1069: an antagonist to the X retinoid receptor].
by Lansiaux, A
410 Bexarotene (LGD1069, Targretin), a selective retinoid X receptor agonist, prevents and reverses gemcitabine resistance in NSCLC cells by modulating gene amplification.
by Tooker, Patricia
411 Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
by Mehta, Neha
412 Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
by Kim, Mi-Sung
413 Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials.
by Prince, H M
414 Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.
by Medina, Daniel
415 The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
by Li, Y
416 The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
by Lerner, Vladimir
417 ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice.
by Corona, Angela W
418 Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
by Sokolowska-Wojdylo, Malgorzata
419 Omega-3 fatty acids as adjunctive treatment for bexarotene-induced hypertriglyceridaemia in patients with cutaneous T-cell lymphoma.
by Cabello, I
420 Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T-cell lymphoma.
by Morita, Akimichi